4 unknown. 4 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 4 |
| Phase 3 | 2 | Unknown 2 |
Follow SOC: new trials by email Literature Review of SOC trials Research Report on SOC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities Ropeginterferon alfa-2b, SOC - COVID-19 | Phase 2 / Phase 3 | Unknown | National Taiwan University Hospital | 60 | 2023-05-15 | 2023-04-11 |
| Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy VM-1500A-LAI, Standard of Care - HIV-1-infection | Phase 2 / Phase 3 | Unknown | Viriom | 438 | 2022-04-01 | 2022-01-24 |
| Prevention and Treatment With Hydroxychloroquine + Azithromycin of Acute Respiratory Syndrome Induced by COVID-19 Hydroxychloroquine Pill + Azithromycin Pill, SOC - Acute Respiratory Distress Syndrome, Covid19 | Phase 2 | Unknown | Maimónides Biomedical Research Institute of Córdoba | 132 | 2021-02-10 | 2021-07-08 |
| CHRONVAC-C Study Followed by Standard of Care in Chronic Hepatitis C Virus (HCV) Subjects ChronVac-C + SOC, SOC - Chronic Hepatitis C | Phase 2 | Unknown | ChronTech Pharma AB | 32 | 2011-04-01 | 2011-10-12 |
COVID-19 (2) · Hepatitis C, Chronic (1) · Respiratory Distress Syndrome (1)
ChronTech Pharma AB (1) · Maimónides Biomedical Research Institute of Córdoba (1) · National Taiwan University Hospital (1) · Viriom (1)
Russia (1) · Spain (1) · Sweden (1) · Taiwan (1)
Anastasia Pokrovskaya, PhD (1) · Anders G Vahlne, Professor (1) · Ola RH Weiland, Professor (1) · Wang-Huei Sheng, M.D. Ph.D (1)